HIVOLUTION
ActiveSummary
HIVOLUTION has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €102,241 and a net result of €57,778. Equity is growing by ~41.1% per year across the filed fiscal years. Its solvency ranks better than 53% of 38,911 sector peers (NACE 70, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €59,482 ▲55.9%
Operating result €76,630, net result €59,482, both a record.
31-12
Financial
Liquidity doublescurrent ratio 8.35
Current ratio from 3.92 to 8.35; short-term debt falls from €24,309 to €18,948.
31-12
Financial
Equity above €150,000Eq €152,541 ▲62.5%
3 profitable years in a row build equity to €152,541.
26-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €38,161 ▼30.2%
Net result drops to €38,161, the lowest in the series; recovery starts the following year.
04-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.